CUREL ALPHA HYDROXY DRY SKIN LOTION 4 %
PETROLATUM : 4 % GLYCERINE : 12 % LACTIC ACID : 5 % · DIN 02240161 · JERGENS CANADA INC.
Health Canada status: CANCELLED POST MARKET
What is CUREL ALPHA HYDROXY DRY SKIN LOTION?
CUREL ALPHA HYDROXY DRY SKIN LOTION 4 % contains PETROLATUM : 4 % GLYCERINE : 12 % LACTIC ACID : 5 %. It is listed in the Health Canada Drug Product Database under DIN 02240161, held by JERGENS CANADA INC., supplied as LOTION for TOPICAL administration. Health Canada currently lists it as cancelled post market, status dated 01-Aug-2003. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02240161 |
|---|---|
| Brand name | CUREL ALPHA HYDROXY DRY SKIN LOTION |
| Generic / active ingredient | PETROLATUM : 4 % GLYCERINE : 12 % LACTIC ACID : 5 % |
| Manufacturer | JERGENS CANADA INC. |
| Strength | 4 % |
| Dosage form | LOTION |
| Route of administration | TOPICAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | D02AC SOFT PARAFFIN AND FAT PRODUCTS |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 01-Aug-2003 |
What can be used instead?
Other Canadian products sharing ATC code D02AC SOFT PARAFFIN AND FAT PRODUCTS. 15 of 111 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| AQUAPHOR HEALING OINTMENT | 52.74 % | OINTMENT | BEIERSDORF CANADA INC | MARKETED | DIN 02446189 |
| BABY HEALING OINTMENT | 46.5 % | OINTMENT | CERAVE CANADA | MARKETED | DIN 02512033 |
| BAG BALM SKIN MOISTURIZER | 84.3 % | OINTMENT | VERMONT'S ORIGINAL LLC | MARKETED | DIN 02517574 |
| CRITIC-AID CLEAR | 71.5 % | OINTMENT | COLOPLAST A/S | MARKETED | DIN 02277778 |
| DIABETICS' DRY SKIN RELIEF FOOT CREAM | 30 % | CREAM | SANOFI CONSUMER HEALTH INC | MARKETED | DIN 02418347 |
| HEALING OINTMENT | 46.5 % | OINTMENT | CERAVE CANADA | MARKETED | DIN 02462915 |
| HUILE DE BAIN THERAPEUTIQUE | 3 % | SOLUTION | LABORATOIRE ATLAS INC | MARKETED | DIN 01939068 |
| LIGHT MINERAL OIL 100% NF | 100 % | LIQUID | RW CONSUMER PRODUCTS LTD | MARKETED | DIN 01935321 |
| MINERALE LEGERE HUILE | 100 % | LIQUID | LABORATOIRE ATLAS INC | MARKETED | DIN 00050520 |
| OINTMENT WITH MOISTURIZING VITAMIN E | 95.7 % | OINTMENT | CRLS | MARKETED | DIN 02399954 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.